Literature DB >> 25460004

Probing the target-specific inhibition of sensitized protein tyrosine phosphatases with biarsenical probes.

Adam Pomorski1, Justyna Adamczyk, Anthony C Bishop, Artur Krężel.   

Abstract

Selective control of enzyme activity is critical for elucidating the roles of specific proteins in signaling pathways. One potential means for developing truly target-specific inhibitors involves the use of protein engineering to sensitize a target enzyme to inhibition by a small molecule that does not inhibit homologous wild-type enzymes. Previously, it has been shown that protein tyrosine phosphatases (PTPs) can be sensitized to inhibition by a biarsenical probe, FlAsH-EDT2, which inhibits PTP activity by specifically binding to cysteine residues that have been introduced into catalytically important regions. In the present study, we developed an array of biarsenical probes, some newly synthesized and some previously reported, to investigate for the first time the structure-activity relationships for PTP inhibition by biarsenicals. Our data show that biarsenical probes which contain substitutions at the 2' and 7' positions are more effective than FlAsH-EDT2 at inhibiting sensitized PTPs. The increased potency of 2',7'-substituted probes was observed when PTPs were assayed with both para-nitrophenylphosphate and phosphopeptide PTP substrates and at multiple probe concentrations. The data further indicate that the enhanced inhibitory properties are the result of increased binding affinity between the 2',7'-substituted biarsenical probes and sensitized PTPs. In addition we provide previously unknown physicochemical and stability data for various biarsenical probes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25460004      PMCID: PMC4303503          DOI: 10.1039/c4ob02256d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  25 in total

Review 1.  Novel chemical genetic approaches to the discovery of signal transduction inhibitors.

Authors:  Kevan Shokat; Mark Velleca
Journal:  Drug Discov Today       Date:  2002-08-15       Impact factor: 7.851

Review 2.  Protein tango: the toolbox to capture interacting partners.

Authors:  Anna Rutkowska; Carsten Schultz
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-11       Impact factor: 15.336

Review 3.  Drug discovery and protein tyrosine phosphatases.

Authors:  Mark A T Blaskovich
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B.

Authors:  Z Jia; D Barford; A J Flint; N K Tonks
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

Review 5.  Exploration of biarsenical chemistry--challenges in protein research.

Authors:  Adam Pomorski; Artur Krężel
Journal:  Chembiochem       Date:  2011-04-28       Impact factor: 3.164

6.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

7.  Thiol-dependent recovery of catalytic activity from oxidized protein tyrosine phosphatases.

Authors:  Zachary D Parsons; Kent S Gates
Journal:  Biochemistry       Date:  2013-09-04       Impact factor: 3.162

8.  A long-wavelength fluorescent substrate for continuous fluorometric determination of alpha-mannosidase activity: resorufin alpha-D-mannopyranoside.

Authors:  Daniel J Coleman; Douglas A Kuntz; Meenakshi Venkatesan; Gabriele M Cook; Staci P Williamson; David R Rose; John J Naleway
Journal:  Anal Biochem       Date:  2009-12-21       Impact factor: 3.365

9.  Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition.

Authors:  M Sarmiento; Y A Puius; S W Vetter; Y F Keng; L Wu; Y Zhao; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

10.  New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications.

Authors:  Stephen R Adams; Robert E Campbell; Larry A Gross; Brent R Martin; Grant K Walkup; Yong Yao; Juan Llopis; Roger Y Tsien
Journal:  J Am Chem Soc       Date:  2002-05-29       Impact factor: 15.419

View more
  5 in total

1.  Rotamer-Restricted Fluorogenicity of the Bis-Arsenical ReAsH.

Authors:  Allison S Walker; Paul R Rablen; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2016-05-10       Impact factor: 15.419

2.  Optimized allosteric inhibition of engineered protein tyrosine phosphatases with an expanded palette of biarsenical small molecules.

Authors:  Samuel Korntner; Adam Pomorski; Artur Krężel; Anthony C Bishop
Journal:  Bioorg Med Chem       Date:  2018-04-12       Impact factor: 3.641

3.  In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus.

Authors:  Zhong Li; Jimin Xu; Yuekun Lang; Xiangmeng Wu; Saiyang Hu; Subodh Kumar Samrat; Anil M Tharappel; Lili Kuo; David Butler; Yongcheng Song; Qing-Yu Zhang; Jia Zhou; Hongmin Li
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

4.  Synthesis, bioactivity, 3D-QSAR studies of novel dibenzofuran derivatives as PTP-MEG2 inhibitors.

Authors:  Ying Ma; Hui-Yu Wei; Yu-Ze Zhang; Wen-Yan Jin; Hong-Lian Li; Hui Zhou; Xian-Chao Cheng; Run-Ling Wang
Journal:  Oncotarget       Date:  2017-06-13

5.  Synthesis of Arylazide- and Diazirine-Containing CrAsH-EDT2 Photoaffinity Probes.

Authors:  Shameem S Syeda; Daren Rice; Derek J Hook; Leslie L Heckert; Gunda I Georg
Journal:  Arch Pharm (Weinheim)       Date:  2016-03-07       Impact factor: 3.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.